1,2-Dichloroethane → 4-(5-bromo-2-chloropyrimidin-4-yl)-N-((R)-1-(4-chlorophenyl)ethyl)morpholine-3-carboxamide
反応式
[Br:1][C:2]1[C:3]([N:9]2[CH2:14][CH2:13][O:12][CH2:11][CH:10]2[C:15]([OH:17])=O)=[N:4][C:5]([Cl:8])=[N:6][CH:7]=1.C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.[Cl:32][C:33]1[CH:38]=[CH:37][C:36]([C@H:39]([NH2:41])[CH3:40])=[CH:35][CH:34]=1.C(N(CC)CC)C>CN(C=O)C.C(OCC)(=O)C>[Br:1][C:2]1[C:3]([N:9]2[CH2:14][CH2:13][O:12][CH2:11][CH:10]2[C:15]([NH:41][C@@H:39]([C:36]2[CH:37]=[CH:38][C:33]([Cl:32])=[CH:34][CH:35]=2)[CH3:40])=[O:17])=[N:4][C:5]([Cl:8])=[N:6][CH:7]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
4-(5-Bromo-2-chloropyrimidin-4-yl)morpholine-3-carboxylic acid (PREPARATION x30, 1 g, 3.10 mmol), EDC (0.892 g, 4.65 mmol), HOBt (0.712 g, 4.65 mmol), (R)-1-(4-chlorophenyl)ethanamine (0.724 g, 4.65 mmol) and triethylamine (1.296 mL, 9.30 mmol) were dissolved in DMF (15 mL). The resulting brown solution was stirred at room temperature for 18 hours and was subsequently diluted with ethyl acetate and washed with aqueous saturated NH4Cl (3×25 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo to give a crude product which was loaded onto an ISCO® silica gel cartridge (40 g) and eluted using an ethyl acetate/hexane gradient. The product was collected and concentrated in vacuo to afford the title compound as a yellow foam (574 mg, 40%). 1H NMR (400 MHz, DMSO-d6) δ 1.38 (dd, J=7.07, 4.29 Hz, 3H), 3.55 (d, J=6.32 Hz, 2H), 3.68-3.79 (m, 1H), 3.84-3.91 (m, 1H), 4.22-4.39 (m, 2H), 4.86 (m, 1H), 4.89-5.03 (m, 1H), 7.31-7.41 (m, 4H), 8.45 (d, J=10.61 Hz, 2H).
後処理
- washwashed with aqueous saturated NH4Cl (3×25 mL)
- dry with materialThe combined organic layers were dried over MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customto give a crude product which
- washeluted
- customThe product was collected
- concentrationconcentrated in vacuo
出典と根拠
- ORDレコード
- ord-fa7389bd5dc24c38ba2fbf5f6c7ef0c9
- 出典データセット
- uspto-grants-2014_07
- 特許番号
- US08791107B2
反応ノート
読み込み中…